May 7: The Week in Cancer News
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Progress Against Cancer
A Food and Drug Administration panel recommends withdrawing approvals for two treatment indications for immunotherapy drugs, and more news of the week from Cancer Today.
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells (giving rise to myeloma). In 2020 alone, there were an estimated 1.3 million new blood cancer cases worldwide, which accounted for more than 5 percent of all cancer diagnoses that...
Many patients facing a cancer diagnosis ask their doctors a simple question: “What should I eat?” That elemental question has perplexed scientists for centuries. In a stirring discussion during the Opening Plenary session of...
President Biden resurfaces a proposal for a new health care agency, and more news of the week from Cancer Today.
The term “cancer” encompasses a broad range of diseases that can afflict almost any organ of the body. Not only do molecular features and clinical outcomes vary widely between different cancer types, but they can even differ between individuals who have...
Anti-racism activist and historian Ibram X. Kendi opens up about his stage IV colon cancer treatment and more cancer research news of the week from Cancer Today magazine.
Stool-based tests were favored over colonoscopy for colorectal cancer screening, according to research published in the AACR journal Cancer Prevention Research.
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
Immunotherapy has revolutionized cancer treatment over the past decade, providing potentially lifesaving therapies to many patients who otherwise would have limited options. Despite its success for many patients, immunotherapy still has challenges to overcome. Fortunately, novel strategies to improve the efficacy...
The immune systems of people with blood cancer respond differently to the coronavirus than the immune systems of people without cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 48,000 members worldwide drive progress against cancer.
Donate Now